Fabienne Warmerdam
Papers
4
Total Citations
25
H-Index
2
About
Fabienne Warmerdam is a rising surgical oncologist whose research is reshaping how we understand and optimize rectal cancer surgery. Her work centers on the comparative effectiveness of different total mesorectal excision (TME) techniques—open, laparoscopic, robot-assisted, and transanal—with a sharp focus on what matters most to patients: functional outcomes and quality of life. Her landmark 2024 systematic review and meta-analysis, already garnering 16 citations, critically synthesized evidence across these approaches, revealing crucial trade-offs between oncologic safety and postoperative function. Warmerdam has also led the EUREKA collaborative, a multinational cohort study protocol evaluating robotic rectal cancer surgery outcomes, demonstrating her capacity to coordinate large-scale, real-world evidence generation. Her subsequent studies have tackled high-stakes clinical challenges, including the impact of obesity on minimally invasive TME and the development of a predictive risk model for positive circumferential resection margins after robotic surgery—a key predictor of recurrence and survival. Through these contributions, Warmerdam is providing surgeons with the data needed to tailor operative approaches to individual patient risk profiles, moving the field toward more personalized, function-preserving rectal cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4